Invo Bioscience Inc. (OTCMKTS:IVOB) Dips Even Further

Unsurprisingly, Invo Bioscience Inc. (OTCMKTS:IVOB) lost another 11.46% on Friday, and at this point it looks like this has become the norm for the ticker.

This turn of events is hardy surprising for seasoned investors. After all, it was clear from the get-go that what IVOB was experiencing was a massive hype surge – and such jumps have a tendency to crash horribly if there is nothing to keep the ticker afloat after the fact.

Unfortunately for IVOB enthusiasts, this seems to be what the market has in store for the ticker. True, the company made some very bold claims – but then it did nothing to back them up. It has been more than ten days since its big, impressive announcement, and in that ten days, literally nothing else has happened. IVOB has done nothing to amend the void in its filings and public relations after throwing that piece of PR up in the air.

It is only natural that investors will not stay impressed with news, no matter how bold the announcements are, for too long and IVOB has given them nothing further to go on. Which is why the ticker is falling, and will most likely continue its downward course until some radical new development about IVOB becomes public knowledge.

It would be a safe bet to say that this is the only scenario in which IVOB‘s course may be changed. Investors need to be convinced to commit to a company’s stock. If IVOB manages to do that, it may yet make another explosive run up the charts. Until that happens, however, its market cap will probably continue shrinking – and at the way things are going, if nothing changes, it wouldn’t be all that surprising to see the ticker fall back below $0.5 before too long.